Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Difficult Differential Diagnosis of Paraneoplastic Neuromuscular Diseases Associated with Small Cell lung Cancer: A Report of Two Cases.
Umemoto K, Tomomatsu K, Urata M, Okazaki E, Yamazaki K, Yoshikawa T, Okada N, Hattori S, Takeuchi T, Horio Y, Takiguchi H, Niimi K, Hayama N, Ito Y, Imazeki R, Oguma T, Nagata E, Asano K. Umemoto K, et al. Among authors: yamazaki k. Tokai J Exp Clin Med. 2024 Dec 20;49(4):144-147. Tokai J Exp Clin Med. 2024. PMID: 39572882 Free article.
Evidence for successful gastric perfusion computed tomography with low-radiation dose.
Kushida K, Tamazawa M, Matsumoto M, Yamazaki K, Shimizu E, Kaneyama A, Miyahara S, Yoshimura A, Iseri T, Tashiro K, Katayama M, Fukushima R, Kishimoto M. Kushida K, et al. Among authors: yamazaki k. Am J Vet Res. 2025 Jan 23:1-5. doi: 10.2460/ajvr.24.08.0227. Online ahead of print. Am J Vet Res. 2025. PMID: 39847860 Free article.
Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA.
Taniguchi Y, Tamiya A, Osuga M, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Shimada M, Ando M, Koh Y. Taniguchi Y, et al. Among authors: yamazaki k. Invest New Drugs. 2025 Jan 9. doi: 10.1007/s10637-024-01500-9. Online ahead of print. Invest New Drugs. 2025. PMID: 39789369
Assessment of heterogeneity according to hospital or medical experience factors in outcomes of chemotherapy for advanced biliary tract cancer: a post-hoc analysis of JCOG1113.
Fukushi K, Imaoka H, Ikeda M, Mizusawa J, Morizane C, Okusaka T, Kobayashi S, Sasahira N, Shimizu S, Yamazaki K, Okano N, Miwa H, Hara K, Satoi S, Sano K, Sakai K, Sugimoto R, Nakamura K, Terashima T, Ozaka M, Ueno M; JCOG Hepatobiliary and Pancreatic Oncology Group. Fukushi K, et al. Among authors: yamazaki k. Jpn J Clin Oncol. 2025 Jan 8:hyae188. doi: 10.1093/jjco/hyae188. Online ahead of print. Jpn J Clin Oncol. 2025. PMID: 39775866
Prevalence and clinicopathological features of microsatellite instability-high metastatic or recurrent gastric and esophagogastric junction cancer: WJOG13320GPS.
Komori A, Hironaka S, Kadowaki S, Mitani S, Furuta M, Kawakami T, Makiyama A, Takegawa N, Sugiyama K, Hirano H, Ando T, Matsushima T, Chida A, Kashiwada T, Komoda M, Matsumoto T, Oda H, Yabusaki H, Kawakami H, Yamazaki K, Boku N, Hyodo I, Yoshimura K, Muro K; West Japan Oncology Group (WJOG). Komori A, et al. Among authors: yamazaki k. Gastric Cancer. 2024 Dec 31. doi: 10.1007/s10120-024-01579-2. Online ahead of print. Gastric Cancer. 2024. PMID: 39738793
3,356 results